Teva (TEVA) Backed a Bid of Up to $125M in Cash Plus Assumed Liabilities for BioXcel’s Assets. Is Bankruptcy-Sale Risk Worth the At-Home Opportunity?

Yahoo Finance· Sep 4, 2026 · 4:01 PM

This is a summary. Read the complete story at Yahoo Finance below.

Read full article at Yahoo Finance

I’m 77, pay rent and live off Social Security, but I help homeless people. Why are so many people going hungry?

“I am a retired senior citizen living check-to-check.”

MarketWatch

marketsabout 2 hours ago

How to keep profiting from AI while shielding your portfolio against the risk of a slowdown

Jamie Wilhelm and Sunit Gogia of Fort Washington Investment Advisors expect the AI wave to continue, but describe leading indicators of an eventual downturn.

MarketWatch

marketsabout 2 hours ago

From $6 eggs to $50,000 cars, these charts show how inflation has defined the past 5 years

Rising prices have been crushing consumer confidence and biting at Americans’ wallets for more than five years now.

MarketWatch

Teva (TEVA) Backed a Bid of Up to $125M in Cash Plus Assumed Liabilities for BioXcel’s Assets. Is Bankruptcy-Sale Risk Worth the At-Home Opportunity?

Related Stories

I’m 77, pay rent and live off Social Security, but I help homeless people. Why are so many people going hungry?

How to keep profiting from AI while shielding your portfolio against the risk of a slowdown

From $6 eggs to $50,000 cars, these charts show how inflation has defined the past 5 years